SEATTLE (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Thursday reported a loss of $8.1 million in its fourth quarter.
On a per-share basis, the Seattle-based company said it had a loss of 23 cents.
For the year, the company reported that its loss widened to $69.4 million, or $2.57 per share.
Neoleukin shares have declined 39% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $7.53, nearly tripling in the last 12 months.